No Data
No Data
Renhe Pharmaceutical: 2024 Semi-Annual Report Summary
Renhe Pharmaceutical: 2024 Semi-Annual Report
Renhe Pharmacy (000650.SZ): The net income for the first half of the year was 0.337 billion yuan, a decrease of 5.43% year-on-year.
Renhe Pharmacy (000650.SZ) announced its interim report for the first half of 2024, with operating revenue of 2.364 billion yuan, a decrease of 11.84% year-on-year. Net income attributable to shareholders of the listed company was 0.337 billion yuan, a decrease of 5.43% year-on-year. Net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 0.252 billion yuan, a decrease of 19.29% year-on-year. Basic earnings per share were 0.2409 yuan.
Investors Three-year Losses Continue as Renhe PharmacyLtd (SZSE:000650) Dips a Further 5.2% This Week, Earnings Continue to Decline
As of July 19, 2024, Renhe Pharmacy (000650.SZ) has approximately 0.099 million households.
Renhe Pharmacy (000650.SZ) stated on the investor interaction platform on July 24th that there were approximately 0.099 million households as of July 19, 2024.
Renhe Pharmacy (000650.SZ): As of July 10, the number of shareholders in the company is about 0.098 million households.
Renhe Pharmacy (000650.SZ) stated on the investor interaction platform on July 11th that as of July 10, 2024, the company had approximately 0.098 million shareholders.
No Data
No Data